ProQR Therapeutics N.V. (PRQR) Tops Q1 EPS by 1c

ProQR Therapeutics N.V. (NASDAQ: PRQR) reported Q1 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $4.45 million versus the consensus estimate of $3.14 million.

For earnings history and earnings-related data on ProQR Therapeutics N.V. (PRQR) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• BWS Financial Starts Capstone Energy Plus (CEPL) at Buy
• JD.com, Inc (JD) PT Lowered to $37 at Macquarie ahead of earnings